- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hormonresistent prostatakræft in Canada
I alt 1114 resultater
-
Lawson Health Research InstituteAfsluttet
-
University Health Network, TorontoProstate Cancer CanadaAfsluttet
-
AHS Cancer Control AlbertaAfsluttet
-
AHS Cancer Control AlbertaCross Cancer InstituteAfsluttet
-
University Health Network, TorontoAfsluttetProstatakræftCanada
-
Sunnybrook Health Sciences CentrePhilips HealthcareAfsluttetProstatakræftCanada
-
University Health Network, TorontoAfsluttet
-
Dr. Laurence KlotzUkendt
-
Lawson Health Research InstituteUniversity of Western Ontario, Canada; London Regional Cancer Program,...Afsluttet
-
Sunnybrook Health Sciences CentreToronto Sunnybrook Regional Cancer CentreAfsluttet
-
Alberta Health servicesAfsluttet
-
Canadian Urology Research ConsortiumAstraZenecaAfsluttet
-
University of ManitobaManitoba Medical Service FoundationAfsluttet
-
University of ManitobaHealth Sciences Centre Foundation, ManitobaAfsluttet
-
British Columbia Cancer AgencyUniversity of British Columbia; Vancouver Prostate Centre; BC Cancer FoundationRekrutteringLokaliseret prostatakarcinomCanada
-
Canadian Urology Research ConsortiumFerring PharmaceuticalsAfsluttet
-
Nova Scotia Health AuthorityDalhousie University; Queen Elizabeth II Health Sciences CentreAfsluttet
-
British Columbia Cancer AgencyAfsluttet
-
British Columbia Cancer AgencyAfsluttet
-
British Columbia Cancer AgencyUkendt
-
British Columbia Cancer AgencyUkendt
-
Canadian Urology Research ConsortiumOICR; EigenUkendt
-
University of British ColumbiaUkendt
-
BayerOrion Corporation, Orion PharmaAfsluttetProstatakræft Ikke-metastaserende | KastrationsbestandigBelgien, Frankrig, Polen, Spanien, Canada, Forenede Stater, Estland, Portugal, Taiwan, Japan, Den Russiske Føderation, Finland, Tyskland, Østrig, Tjekkiet, Ungarn, Australien, Brasilien, Sydafrika, Letland, Italien, Det Forenede Kongerige og mere
-
University Health Network, TorontoProstate Cancer CanadaAfsluttet
-
Novartis PharmaceuticalsRekrutteringMetastatisk kastrationsresistent prostatacancer (mCRPC)Spanien, Frankrig
-
University Health Network, TorontoAfsluttetProstatakræft | Forhøjet PSACanada
-
Lawson Health Research InstituteUniversity of Western Ontario, Canada; Lawson Health Research Institute...AfsluttetProstatakræft | KnogletabCanada
-
Nova Scotia Health AuthorityRekruttering
-
British Columbia Cancer AgencyRekrutteringProstatakræftCanada
-
CR-CSSS Champlain-Charles-Le MoyneSuspenderetProstatakræftCanada
-
British Columbia Cancer AgencyUkendt
-
University of British ColumbiaUnited States Department of DefenseAfsluttet
-
Nova Scotia Health AuthorityCanada: Beatrice Hunter Cancer Research InstituteUkendt
-
Vancouver Coastal HealthLotte & John Hecht Memorial FoundationAfsluttet
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); British Columbia Innovation...Afsluttet
-
University of British ColumbiaUkendt
-
Ontario Clinical Oncology Group (OCOG)AfsluttetProstatakræftCanada
-
AHS Cancer Control AlbertaUkendt
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)Afsluttet
-
AmgenAfsluttetSikkerhed, tolerabilitet, farmakokinetik og effektivitet af Acapatamab hos forsøgspersoner med mCRPCProstatakræft | Metastatisk kastrationsresistent prostatakræftForenede Stater, Belgien, Østrig, Singapore, Australien, Holland, Frankrig, Japan, Taiwan, Canada
-
Sir Mortimer B. Davis - Jewish General HospitalRekrutteringProstatakræft | UrinproblemerCanada
-
CHU de Quebec-Universite LavalSunnybrook Health Sciences Centre; Université de MontréalAfsluttet
-
University of Guelph-HumberAfsluttetProstatakræftCanada
-
University of TorontoCanadian Institutes of Health Research (CIHR)RekrutteringStillesiddende adfærd | Kræft i prostataCanada
-
Lawson Health Research InstituteOICRAfsluttet
-
Southlake Regional Health CentreUniversity Health Network, Toronto; Sunnybrook Health Sciences CentreUkendt
-
Dr. Tamim NiaziAstraZenecaAktiv, ikke rekrutterende
-
Sunnybrook Health Sciences CentreRekrutteringProstatakræftCanada